Skip to main content

Market Overview

What's Going On With Palantir Stock And Novavax Stock Today?

What's Going On With Palantir Stock And Novavax Stock Today?

Palantir Technologies Inc (NYSE: PLTR) shares are trading lower by 5.8% at $23.94, despite the company earlier Wednesday announcing a partnership with Clarifai to deliver AI and machine learning algorithms on Palantir's data management platform.

Palantir delivers big data analytics software solutions to United States government projects. Palantir released its Gotham software platform in 2008, which is the platform that primarily focuses on providing data analytics solutions to the U.S. government’s intelligence and defense sectors.

See also: How to Buy Palantir Technologies (PLTR) Stock

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 2.9% at $200.38, potentially on continued strength following a U.S. pause of J&J's COVID-19 vaccine candidate. U.K. researchers also reportedly said the company's vaccine would be included in its Com-Cov study.

Novavax is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases.


Related Articles (NVAX + PLTR)

View Comments and Join the Discussion!

Posted-In: News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at